Global Clinical Trials Support Services Market Size, Trends & Analysis - Forecasts to 2028 By Services Type (Clinical Trial Site Management, Patient Recruitment Management, Data Management, and Others), By Phase (Phase I, Phase II, Phase III, and Phase IV), By Sponsor (Pharmaceutical Companies, Medical Devices, and Others), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and Competitor Analysis
The global clinical trials support services market is expected to exhibit a CAGR of 6.3% from 2023 to 2028. The clinical trials support services market refers to the industry that provides various services and solutions to pharmaceutical, biotechnology, and medical device companies conducting clinical trials. These services are essential for the planning, execution, monitoring, and managing of clinical trials, which are necessary for bringing new drugs and therapies to market. The clinical trials support services market is crucial for developing functional drugs. It encompasses a variety of services, including clinical research organizations (CROs), technology providers, consulting firms, and regulatory affairs experts. The clinical trials support services market is a dynamic and essential component of the pharmaceutical and biotechnology industries. It offers various services to facilitate the development and regulatory approval of new drugs and therapies while adapting to emerging technologies and regulatory changes.
The global clinical trials support services market is expected to witness rapid growth, driven by several key factors. First, there is a growing demand for clinical trials in emerging economies, where healthcare infrastructure is developing, and patient populations are more diverse. Secondly, pharmaceutical companies are increasing their research and development (R&D) investments, largely due to patent expirations. As patents typically last for 20 years, with a 10-year provision for generic versions, firms are accelerating R&D efforts to bring new drugs to market sooner, thus expanding the entire clinical trials market. Clinical trials support services play a crucial role in drug development, encompassing various tasks from assay design to clinical testing, including patient recruitment, drug storage, dosage calculations, and kit handling. To manage the massive data generated by multicentric trials, clinical data management (CDM) systems, both commercial and free-source tools, are utilized. These systems ensure data integrity, audit trails, and effective data management, contributing to the overall growth of the global clinical trials support services market.
While the clinical trials support services market is on a growth trajectory, it also faces several notable restraints. Regulatory hurdles and compliance complexities can significantly slow down trial processes, increasing costs. Additionally, there is a shortage of qualified personnel in some regions, affecting service quality. Furthermore, the high costs associated with clinical trials, along with patent expirations and competition, are pressuring pharmaceutical firms' R&D budgets.
On the basis of service type, the market is segmented into clinical trial site management, patient recruitment management, data management, and others. The clinical trial site management segment is expected to be the largest segment during the forecast period. This dominance is driven by the increasing number of clinical trials, a high prevalence of chronic diseases, and the expanding presence of contract research organizations (CROs) offering services. Site management is critical as it efficiently recruits, treats, and retains subjects while ensuring regulatory compliance, protocol adherence, subject safety, and overall trial success, making it a significant contributor to trial costs, ranging from 29% to 59% of the total expenditure.
The patient recruitment management segment is expected to be the fastest-growing segment within clinical trials support services due to its critical role in accelerating trial timelines. Advances in data analytics and targeted marketing enable precise patient identification and recruitment. With the rising complexity of trials and competition for suitable participants, pharmaceutical companies and CROs are increasingly investing in efficient patient recruitment solutions to minimize delays and ensure the successful execution of clinical studies, thus driving rapid growth in this segment.
On the basis of phase, the market is segmented into phase I, phase II, phase III, and phase IV. The phase III segment is expected to be the largest segment during the forecast period due to phase III being the most important part of trials. Drug development and approval are impossible without this phase. Moreover, phase III trials test if a new treatment is better than a standard treatment. Thus, phase III trials are a crucial focus area for pharmaceutical firms, driving demand for comprehensive clinical trial support services.
The phase I segment is expected to be the fastest-growing segment in the global clinical trials support services market. This phase includes sample collection management, data management, patient assessment, and assay redesign services. Key regions such as the U.S., Europe, China, Canada, and Australia are vital hubs for phase I trials, driving the demand for clinical trial management services as they play a pivotal role in ensuring the successful initiation and management of these critical early-stage trials.
On the basis of sponsor, the market is segmented into pharmaceutical companies, medical devices, and others. The pharmaceutical companies’ segment is expected to be the largest segment during the forecast period. This is due to its substantial R&D investments, driven by the need to develop new drugs and therapies. For instance, in December 2020, Cerner Corporation announced an investment in Elligo Health Research, a leading integrated research organization that enables clinical trials with nationwide community-based health care practices. With patents expiring after 20 years and provisions for generic versions after 10 years, firms are intensifying their R&D efforts, boosting the demand for clinical trials. Additionally, pharmaceutical companies have a dominant role in drug development, making them the primary clientele for clinical trials support services.
The medical device companies’ segment is expected to be the fastest-growing segment in the global clinical trials support services market due to several factors. With a rising demand for advanced healthcare technologies, medical device firms are investing significantly in clinical trials, leading to a rapid expansion of the segment as they strive to bring innovative products to market, thus driving growth in the overall market.
North America is analysed to account for the largest share in the global clinical trials support services market during the forecast period. This dominance is primarily attributed to the concentration of pharmaceutical businesses, particularly in the United States, which conduct a significant portion of their operations within the region. North America's leadership position is further bolstered by the high volume of clinical trials conducted there. Robust R&D investments and government backing for clinical research initiatives also fuel market expansion. For example, in December 2021, IQVIA introduced Research Nursing and Phlebotomy services. They give clinical trial patients access to skilled professionals for at-home, protocol-required care worldwide. The presence of key clinical research organizations (CROs) offering comprehensive clinical trial support services, coupled with substantial investments by multinational pharmaceutical and biopharmaceutical companies in clinical research endeavours, further supports North America's prominence in this sector.
Asia Pacific is expected to be the fastest growing region across the global clinical trials support services market. Several factors contribute to this remarkable growth. Firstly, APAC exhibits a rapidly increasing patient population, providing a diverse pool for clinical trials. Secondly, the region offers simplified administrative compliance procedures, reducing bureaucratic hurdles. Thirdly, conducting studies in APAC is cost-effective compared to many Western counterparts, making it an attractive destination. Lastly, the presence of top-tier clinical organizations operating in the region enhances the infrastructure and expertise available for conducting clinical trials, further propelling APAC's prominence in the market.
Key players operating in the global clinical trials support services market include Charles River Laboratories, Wuxi Apptec Inc., Iqvia Holdings, Syneos Health, Eurofins Scientific, PPD Inc., Icon Plc, Labcorp, Alcura, and Parexel Corp., among others.
Please note: This is not an exhaustive list of companies profiled in the report.
In April 2019, the WuXi AppTec acquired a clinical research services company, Pharmapace Inc., to expand its biometrics offerings in clinical research with data management, statistical programming, clinical data integration, biostatistics, and medical writing.
1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS
1.1 Strategic Opportunity & Attractiveness Analysis
1.1.1 Hot Revenue Pockets
1.1.2 Market Attractiveness Score
1.1.3 Revenue Impacting Opportunity
1.1.4 High Growing Region/Country
1.1.5 Competitor Analysis
1.1.6 Consumer Analysis
1.2 Global Market Estimates' View
1.3 Strategic Insights across Business Functions
1.3.1 For Chief Executive Officers
1.3.2 For Chief Marketing Officers
1.3.3 For Chief Strategy Officers
1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into
2.1 Technological Adoption Rate
2.2 Current Trend Impact Analysis
2.3 Future Trend Impact Analysis
2.4 Data Metrics on Feed Stocks
3.1.2 Adjacent Market Opportunities
3.1.3 Ancillary Market Opportunities
3.2.1 Market Drivers: Impact Analysis
3.2.2 Market Restraints: Impact Analysis
3.2.3 Market Opportunities: Impact Analysis
3.2.4 Market Challenges: Impact Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Threat of New Entrants
3.3.1.2 Threat of New Substitutes
3.3.1.3 Bargaining Power of Suppliers
3.3.1.4 Bargaining Power of Buyers
3.3.1.5 Intensity of Competitive Rivalry
3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
4 GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR
4.2 Clinical Trials Support Services Market: Sponsor Scope Key Takeaways
4.3 Revenue Growth Analysis, 2022 & 2028
4.4.1 Pharmaceutical Companies Market Estimates and Forecast, 2020-2028 (USD Billion)
4.5.1 Medical Devices Market Estimates and Forecast, 2020-2028 (USD Billion)
4.6.1 Other Sponsors Market Estimates and Forecast, 2020-2028 (USD Billion)
5 GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE TYPE
5.2 Clinical Trials Support Services Market: Service Type Scope Key Takeaways
5.3 Revenue Growth Analysis, 2022 & 2028
5.4 Clinical Trial Site Management
5.4.1 Clinical Trial Site Management Market Estimates and Forecast, 2020-2028 (USD Billion)
5.5 Patient Recruitment Management
5.5.1 Patient Recruitment Management Market Estimates and Forecast, 2020-2028 (USD Billion)
5.6.1 Data Management Market Estimates and Forecast, 2020-2028 (USD Billion)
5.7.1 Other Services Market Estimates and Forecast, 2020-2028 (USD Billion)
6 GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE
6.2 Clinical Trials Support Services Market: Phase Scope Key Takeaways
6.3 Revenue Growth Analysis, 2022 & 2028
6.4.1 Phase I Market Estimates and Forecast, 2020-2028 (USD Billion)
6.5.1 Phase II Market Estimates and Forecast, 2020-2028 (USD Billion)
6.6.1 Phase III Market Estimates and Forecast, 2020-2028 (USD Billion)
6.7.1 Phase IV Market Estimates and Forecast, 2020-2028 (USD Billion)
6.8.1 Other Users Market Estimates and Forecast, 2020-2028 (USD Billion)
7 GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY REGION
7.2.4.1 U.S. Clinical Trials Support Services Market Estimates and Forecast, 2020-2028 (USD Billion)
7.3 Europe Clinical Trials Support Services Market Estimates and Forecast, 2020-2028 (USD Billion)
7.3.4.2 U.K. Clinical Trials Support Services Market Estimates and Forecast, 2020-2028 (USD Billion)
8.1 Company Market Share Analysis
8.2 Four Quadrant Positioning Matrix
8.4.1 Charles River Laboratories
8.4.1.1 Business Description & Financial Analysis
8.4.1.3 Products & Services Offered
8.4.1.4 Strategic Alliances between Business Partners
8.4.2.1 Business Description & Financial Analysis
8.4.2.3 Products & Services Offered
8.4.2.4 Strategic Alliances between Business Partners
8.4.3.1 Business Description & Financial Analysis
8.4.3.3 Products & Services Offered
8.4.3.4 Strategic Alliances between Business Partners
8.4.4.1 Business Description & Financial Analysis
8.4.4.3 Products & Services Offered
8.4.4.4 Strategic Alliances between Business Partners
8.4.5 Eurofins Scientific, Inc.
8.4.5.1 Business Description & Financial Analysis
8.4.5.3 Products & Services Offered
8.4.5.4 Strategic Alliances between Business Partners
8.4.7.1 Business Description & Financial Analysis
8.4.7.3 Products & Services Offered
8.4.7.4 Strategic Alliances between Business Partners
8.4.7.1 Business Description & Financial Analysis
8.4.7.3 Products & Services Offered
8.4.8.4 Strategic Alliances between Business Partners
8.4.8.1 Business Description & Financial Analysis
8.4.8.3 Products & Services Offered
8.4.8.4 Strategic Alliances between Business Partners
8.4.9.1 Business Description & Financial Analysis
8.4.9.3 Products & Services Offered
8.4.9.4 Strategic Alliances between Business Partners
8.4.10.1 Business Description & Financial Analysis
8.4.10.3 Products & Services Offered
8.4.10.4 Strategic Alliances between Business Partners
9.1.2 Market Scope & Segmentation
9.2.1.2 GMEs Internal Data Repository
9.2.1.3 Secondary Resources & Third Party Perspectives
9.2.1.4 Company Information Sources
9.2.2.1 Various Types of Respondents for Primary Interviews
9.2.2.2 Number of Interviews Conducted throughout the Research Process
9.2.2.4 Discussion Guide for Primary Participants
9.2.3.1 Expert Panels Across 30+ Industry
9.2.4.1 Paid Local Experts Across 30+ Industry Across each Region
9.3.1.1 Macro-Economic Indicators Considered
9.3.1.2 Micro-Economic Indicators Considered
9.3.2.1 Company Share Analysis Approach
9.3.2.2 Estimation of Potential Product Sales
9.4.2 Time Series, Cross Sectional & Panel Data Analysis
9.5.1 Inhouse AI Based Real Time Analytics Tool
9.5.2 Output From Desk & Primary Research
9.6 Research Assumptions & Limitations
LIST OF TABLES
1 Global Clinical Trials Support Services Market, By Sponsor, 2020-2028 (USD Billion)
2 Pharmaceutical Companies Market, By Region, 2020-2028 (USD Billion)
3 Medical Devices Market, By Region, 2020-2028 (USD Billion)
4 Other Sponsors Market, By Region, 2020-2028 (USD Billion)
5 Global Clinical Trials Support Services Market, By Service Type, 2020-2028 (USD Billion)
6 Clinical Trial Site Management Market, By Region, 2020-2028 (USD Billion)
7 Patient Recruitment Management Market, By Region, 2020-2028 (USD Billion)
8 Data Management Market, By Region, 2020-2028 (USD Billion)
9 Other Services Market, By Region, 2020-2028 (USD Billion)
10 Global Clinical Trials Support Services Market, By Phase, 2020-2028 (USD Billion)
11 Phase I Market, By Region, 2020-2028 (USD Billion)
12 PhaSE II Market, By Region, 2020-2028 (USD Billion)
13 Phase III Market, By Region, 2020-2028 (USD Billion)
14 Phase IV Market, By Region, 2020-2028 (USD Billion)
15 Regional Analysis, 2020-2028 (USD Billion)
16 North America Clinical Trials Support Services Market, By Sponsor, 2020-2028 (USD Billion)
17 North America Clinical Trials Support Services Market, By Service Type, 2020-2028 (USD Billion)
18 North America Clinical Trials Support Services Market, By Phase, 2020-2028 (USD Billion)
19 North America Clinical Trials Support Services Market, By Country, 2020-2028 (USD Billion)
20 U.S. Clinical Trials Support Services Market, By Sponsor, 2020-2028 (USD Billion)
21 U.S. Clinical Trials Support Services Market, By Service Type, 2020-2028 (USD Billion)
22 U.S Clinical Trials Support Services Market, By Phase, 2020-2028 (USD Billion)
23 Canada Clinical Trials Support Services Market, By Sponsor, 2020-2028 (USD Billion)
24 Canada Clinical Trials Support Services Market, By Service Type, 2020-2028 (USD Billion)
25 Canada Clinical Trials Support Services Market, By Phase, 2020-2028 (USD Billion)
26 Mexico Clinical Trials Support Services Market, By Sponsor, 2020-2028 (USD Billion)
27 Mexico Clinical Trials Support Services Market, By Service Type, 2020-2028 (USD Billion)
28 Mexico Clinical Trials Support Services Market, By Phase, 2020-2028 (USD Billion)
29 Europe Clinical Trials Support Services Market, By Sponsor, 2020-2028 (USD Billion)
30 Europe Clinical Trials Support Services Market, By Service Type, 2020-2028 (USD Billion)
31 Europe Clinical Trials Support Services Market, By Phase, 2020-2028 (USD Billion)
32 Germany Clinical Trials Support Services Market, By Sponsor, 2020-2028 (USD Billion)
33 Germany Clinical Trials Support Services Market, By Service Type, 2020-2028 (USD Billion)
34 Germany Clinical Trials Support Services Market, By Phase, 2020-2028 (USD Billion)
35 U.K. Clinical Trials Support Services Market, By Sponsor, 2020-2028 (USD Billion)
36 U.K. Clinical Trials Support Services Market, By Service Type, 2020-2028 (USD Billion)
37 U.K. Clinical Trials Support Services Market, By Phase, 2020-2028 (USD Billion)
38 France Clinical Trials Support Services Market, By Sponsor, 2020-2028 (USD Billion)
39 France Clinical Trials Support Services Market, By Service Type, 2020-2028 (USD Billion)
40 France Clinical Trials Support Services Market, By Phase, 2020-2028 (USD Billion)
41 Italy Clinical Trials Support Services Market, By Sponsor, 2020-2028 (USD Billion)
42 Italy Clinical Trials Support Services Market, By T Service Type Type, 2020-2028 (USD Billion)
43 Italy Clinical Trials Support Services Market, By Phase, 2020-2028 (USD Billion)
44 Spain Clinical Trials Support Services Market, By Sponsor, 2020-2028 (USD Billion)
45 Spain Clinical Trials Support Services Market, By Service Type, 2020-2028 (USD Billion)
46 Spain Clinical Trials Support Services Market, By Phase, 2020-2028 (USD Billion)
47 Rest Of Europe Clinical Trials Support Services Market, By Sponsor, 2020-2028 (USD Billion)
48 Rest Of Europe Clinical Trials Support Services Market, By Service Type, 2020-2028 (USD Billion)
49 Rest of Europe Clinical Trials Support Services Market, By Phase, 2020-2028 (USD Billion)
50 Asia Pacific Clinical Trials Support Services Market, By Sponsor, 2020-2028 (USD Billion)
51 Asia Pacific Clinical Trials Support Services Market, By Service Type, 2020-2028 (USD Billion)
52 Asia Pacific Clinical Trials Support Services Market, By Phase, 2020-2028 (USD Billion)
53 Asia Pacific Clinical Trials Support Services Market, By Country, 2020-2028 (USD Billion)
54 China Clinical Trials Support Services Market, By Sponsor, 2020-2028 (USD Billion)
55 China Clinical Trials Support Services Market, By Service Type, 2020-2028 (USD Billion)
56 China Clinical Trials Support Services Market, By Phase, 2020-2028 (USD Billion)
57 India Clinical Trials Support Services Market, By Sponsor, 2020-2028 (USD Billion)
58 India Clinical Trials Support Services Market, By Service Type, 2020-2028 (USD Billion)
59 India Clinical Trials Support Services Market, By Phase, 2020-2028 (USD Billion)
60 Japan Clinical Trials Support Services Market, By Sponsor, 2020-2028 (USD Billion)
61 Japan Clinical Trials Support Services Market, By Service Type, 2020-2028 (USD Billion)
62 Japan Clinical Trials Support Services Market, By Phase, 2020-2028 (USD Billion)
63 South Korea Clinical Trials Support Services Market, By Sponsor, 2020-2028 (USD Billion)
64 South Korea Clinical Trials Support Services Market, By Service Type, 2020-2028 (USD Billion)
65 South Korea Clinical Trials Support Services Market, By Phase, 2020-2028 (USD Billion)
66 Middle East and Africa Clinical Trials Support Services Market, By Sponsor, 2020-2028 (USD Billion)
67 Middle East and Africa Clinical Trials Support Services Market, By Service Type, 2020-2028 (USD Billion)
68 Middle East and Africa Clinical Trials Support Services Market, By Phase, 2020-2028 (USD Billion)
69 Middle East and Africa Clinical Trials Support Services Market, By Country, 2020-2028 (USD Billion)
70 Saudi Arabia Clinical Trials Support Services Market, By Sponsor, 2020-2028 (USD Billion)
71 Saudi Arabia Clinical Trials Support Services Market, By Service Type, 2020-2028 (USD Billion)
72 Saudi Arabia Clinical Trials Support Services Market, By Phase, 2020-2028 (USD Billion)
73 UAE Clinical Trials Support Services Market, By Sponsor, 2020-2028 (USD Billion)
74 UAE Clinical Trials Support Services Market, By Service Type, 2020-2028 (USD Billion)
75 UAE Clinical Trials Support Services Market, By Phase, 2020-2028 (USD Billion)
76 Central and South America Clinical Trials Support Services Market, By Sponsor, 2020-2028 (USD Billion)
77 Central and South America Clinical Trials Support Services Market, By Service Type, 2020-2028 (USD Billion)
78 Central and South America Clinical Trials Support Services Market, By Phase, 2020-2028 (USD Billion)
79 Central and South America Clinical Trials Support Services Market, By Country, 2020-2028 (USD Billion)
80 Brazil Clinical Trials Support Services Market, By Sponsor, 2020-2028 (USD Billion)
81 Brazil Clinical Trials Support Services Market, By Service Type, 2020-2028 (USD Billion)
82 Brazil Clinical Trials Support Services Market, By Phase, 2020-2028 (USD Billion)
83 Charles River Laboratories: Products & Services Offering
84 Wuxi Apptec: Products & Services Offering
85 Iqvia Holdings: Products & Services Offering
86 Syneos Health: Products & Services Offering
87 Eurofins Scientific, Inc.: Products & Services Offering
88 PPD, INC.: Products & Services Offering
89 Icon Plc : Products & Services Offering
90 Alcura: Products & Services Offering
91 Parexel International, Inc: Products & Services Offering
92 Other Companies: Products & Services Offering
LIST OF FIGURES
1 Global Clinical Trials Support Services Market Overview
2 Global Clinical Trials Support Services Market Value From 2020-2028 (USD Billion)
3 Global Clinical Trials Support Services Market Share, By Sponsor (2022)
4 Global Clinical Trials Support Services Market Share, By Service Type (2022)
5 Global Clinical Trials Support Services Market Share, By Phase (2022)
6 Global Clinical Trials Support Services Market, By Region (Asia Pacific Market)
7 Technological Trends In Global Clinical Trials Support Services Market
8 Four Quadrant Competitor Positioning Matrix
9 Impact Of Macro & Micro Indicators On The Market
10 Impact Of Key Drivers On The Global Clinical Trials Support Services Market
11 Impact Of Challenges On The Global Clinical Trials Support Services Market
12 Porter’s Five Forces Analysis
13 Global Clinical Trials Support Services Market: By Sponsor Scope Key Takeaways
14 Global Clinical Trials Support Services Market, By Sponsor Segment: Revenue Growth Analysis
15 Pharmaceutical Companies Market, By Region, 2020-2028 (USD Billion)
16 Medical Devices Market, By Region, 2020-2028 (USD Billion)
17 Other Sponsors Market, By Region, 2020-2028 (USD Billion)
18 Global Clinical Trials Support Services Market: By Service Type Scope Key Takeaways
19 Global Clinical Trials Support Services Market, By Service Type Segment: Revenue Growth Analysis
20 Clinical Trial Site Management Market, By Region, 2020-2028 (USD Billion)
21 Patient Recruitment Management Market, By Region, 2020-2028 (USD Billion)
22 Data Management Market, By Region, 2020-2028 (USD Billion)
23 Other Services Market, By Region, 2020-2028 (USD Billion)
24 Global Clinical Trials Support Services Market: By Phase Scope Key Takeaways
25 Global Clinical Trials Support Services Market, By Phase Segment: Revenue Growth Analysis
26 Phase I Market, By Region, 2020-2028 (USD Billion)
27 Phase II Market, By Region, 2020-2028 (USD Billion)
28 Phase III Market, By Region, 2020-2028 (USD Billion)
29 Phase IV Market, By Region, 2020-2028 (USD Billion)
30 Regional Segment: Revenue Growth Analysis
31 Global Clinical Trials Support Services Market: Regional Analysis
32 North America Clinical Trials Support Services Market Overview
33 North America Clinical Trials Support Services Market, By Sponsor
34 North America Clinical Trials Support Services Market, By Service Type
35 North America Clinical Trials Support Services Market, By Phase
36 North America Clinical Trials Support Services Market, By Country
37 U.S. Clinical Trials Support Services Market, By Sponsor
38 U.S. Clinical Trials Support Services Market, By Service Type
39 U.S. Clinical Trials Support Services Market, By Phase
40 Canada Clinical Trials Support Services Market, By Sponsor
41 Canada Clinical Trials Support Services Market, By Service Type
42 Canada Clinical Trials Support Services Market, By Phase
43 Mexico Clinical Trials Support Services Market, By Sponsor
44 Mexico Clinical Trials Support Services Market, By Service Type
45 Mexico Clinical Trials Support Services Market, By Phase
46 Four Quadrant Positioning Matrix
47 Company Market Share Analysis
48 Charles River Laboratories: Company Snapshot
49 Charles River Laboratories: SWOT Analysis
50 Charles River Laboratories: Geographic Presence
51 Wuxi Apptec: Company Snapshot
52 Wuxi Apptec: SWOT Analysis
53 Wuxi Apptec: Geographic Presence
54 Iqvia Holdings: Company Snapshot
55 Iqvia Holdings: SWOT Analysis
56 Iqvia Holdings: Geographic Presence
57 Syneos Health: Company Snapshot
58 Syneos Health: Swot Analysis
59 Syneos Health: Geographic Presence
60 Eurofins Scientific, Inc.: Company Snapshot
61 Eurofins Scientific, Inc.: SWOT Analysis
62 Eurofins Scientific, Inc.: Geographic Presence
63 PPD, Inc.: Company Snapshot
64 PPD, Inc.: SWOT Analysis
65 PPD, Inc.: Geographic Presence
66 Icon Plc : Company Snapshot
67 Icon Plc : SWOT Analysis
68 Icon Plc : Geographic Presence
69 Alcura: Company Snapshot
70 Alcura: SWOT Analysis
71 Alcura: Geographic Presence
72 Parexel International, Inc.: Company Snapshot
73 Parexel International, Inc.: SWOT Analysis
74 Parexel International, Inc.: Geographic Presence
75 Other Companies: Company Snapshot
76 Other Companies: SWOT Analysis
77 Other Companies: Geographic Presence
The Global Clinical Trials Support Services Market has been studied from the year 2019 till 2028. However, the CAGR provided in the report is from the year 2023 to 2028. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Clinical Trials Support Services Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS